JP2004526758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526758A5 JP2004526758A5 JP2002580892A JP2002580892A JP2004526758A5 JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5 JP 2002580892 A JP2002580892 A JP 2002580892A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5
- Authority
- JP
- Japan
- Prior art keywords
- tsp
- composition
- angiogenesis inhibitor
- cosmetic
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 10
- 239000004037 angiogenesis inhibitor Substances 0.000 claims 8
- 229940121369 angiogenesis inhibitors Drugs 0.000 claims 8
- 239000002537 cosmetic Substances 0.000 claims 8
- 101710041008 THBS2 Proteins 0.000 claims 4
- 102000007614 Thrombospondin 1 Human genes 0.000 claims 4
- 108010046722 Thrombospondin 1 Proteins 0.000 claims 4
- 239000002994 raw material Substances 0.000 claims 4
- 230000037303 wrinkles Effects 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000036561 sun exposure Effects 0.000 claims 1
- 230000000475 sunscreen Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
Claims (14)
- 血管形成阻害因子を医薬品または化粧品に組み込む段階を含む、長期UVB誘導性のしわの予防または治療において使用するための医薬品または化粧品の製造方法。
- 阻害因子により患者におけるTSP-2またはTSP-1活性が増大される、請求項1記載の方法。
- 血管形成阻害因子がTSP-1またはTSP-2である、請求項1記載の方法。
- 医薬品または化粧品が局所的に投与されるように形成される、請求項1記載の方法。
- 医薬品または化粧品が無菌性組成物として与えられる、請求項1記載の方法。
- 血管形成阻害因子または血管形成阻害因子を誘導する薬剤を含有する長期UVB誘導性のしわを予防または治療するための組成物;および薬学的に許容される担体。
- 血管形成阻害因子がTSP-2またはTSP-1である、請求項6記載の組成物。
- 化粧品原料がさらに含まれる、請求項6記載の組成物。
- 化粧品原料が芳香剤である、請求項8記載の組成物。
- 化粧品原料が日焼け止め剤である、請求項8記載の組成物。
- 患者における長期UVB誘導性のしわを予防するためのキットであって、以下を含むキット:
血管形成阻害因子または血管形成阻害因子を誘導する薬剤を含有する組成物;および
しわを予防するための組成物の使用説明。 - 血管形成阻害因子がTSP-1またはTSP-2である、請求項11記載のキット。
- 組成物に化粧品原料がさらに含まれる、請求項11記載のキット。
- 日光曝露前若しくは日光曝露時に組成物を皮膚に塗布する指示が説明に含まれる、請求項11記載のキット。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28387401P | 2001-04-13 | 2001-04-13 | |
| PCT/US2002/011403 WO2002083088A1 (en) | 2001-04-13 | 2002-04-11 | Methods of preventing uvb-induced skin damage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004526758A JP2004526758A (ja) | 2004-09-02 |
| JP2004526758A5 true JP2004526758A5 (ja) | 2005-08-18 |
Family
ID=23087934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580892A Pending JP2004526758A (ja) | 2001-04-13 | 2002-04-11 | 紫外線ｂにより誘導される皮膚損傷の予防法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6712617B2 (ja) |
| EP (1) | EP1377253A4 (ja) |
| JP (1) | JP2004526758A (ja) |
| KR (2) | KR20040021598A (ja) |
| CN (1) | CN100340287C (ja) |
| CA (1) | CA2446093A1 (ja) |
| TW (1) | TWI233361B (ja) |
| WO (1) | WO2002083088A1 (ja) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266706A1 (en) * | 2002-11-05 | 2004-12-30 | Muthiah Manoharan | Cross-linked oligomeric compounds and their use in gene modulation |
| TWI312681B (en) * | 2001-02-01 | 2009-08-01 | Novel physiologically active substance | |
| TWI334866B (en) * | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
| US7238370B2 (en) * | 2002-06-14 | 2007-07-03 | Rosenberg E William | Method and composition to prevent and treat photoaging of skin |
| EP2465491A1 (en) * | 2002-06-25 | 2012-06-20 | Shiseido Company, Ltd. | Anti-aging preparation |
| CA2494536C (en) * | 2002-07-31 | 2011-10-04 | Mercian Corporation | A 12-membered ring macrolide active substance |
| EP1541570A4 (en) * | 2002-07-31 | 2008-05-21 | Mercian Corp | NEW PHYSIOLOGICALLY ACTIVE SUBSTANCE |
| DE10254214A1 (de) * | 2002-11-20 | 2004-06-09 | Beiersdorf Ag | Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz |
| NZ540103A (en) * | 2002-11-29 | 2007-05-31 | Mercian Corp | Process for producing macrolide compound |
| WO2005097187A2 (en) * | 2004-04-01 | 2005-10-20 | The General Hospital Corporation | Methods of preventing uvb-induced skin damage |
| US20050276762A1 (en) * | 2004-06-15 | 2005-12-15 | Tapas Das | Topical compositions containing 5'-adenosine-diphosphate ribose |
| WO2006042114A1 (en) * | 2004-10-06 | 2006-04-20 | Cook, Inc. | Emboli capturing device having a coil and method for capturing emboli |
| EP3340511B1 (en) | 2004-10-12 | 2022-11-30 | TQ Delta, LLC | Resource sharing in a telecommunications enviroment |
| EP1880007A2 (en) | 2005-05-05 | 2008-01-23 | Genencor International, Inc. | Personal care compositions and methods for their use |
| EP2561883A3 (en) * | 2005-09-16 | 2013-04-17 | Shiseido Company, Ltd. | Novel vascular endothelial growth factor expression inhibitors |
| KR20080087164A (ko) | 2006-01-18 | 2008-09-30 | 더 제너럴 하스피탈 코포레이션 | 림프 기능을 증가시키는 방법 |
| EP2005674B1 (en) | 2006-04-12 | 2016-09-28 | TQ Delta, LLC | Packet retransmission and memory sharing |
| WO2008005533A2 (en) * | 2006-07-06 | 2008-01-10 | Aaron Thomas Tabor | Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance |
| JPWO2008020584A1 (ja) * | 2006-08-14 | 2010-01-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 安定な凍結乾燥製剤 |
| EP2116542A4 (en) * | 2007-01-29 | 2011-05-04 | Eisai R&D Man Co Ltd | SOLID OF A MAKROLIDE COMPOUND, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH |
| CA2698812A1 (en) | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
| CN102471769A (zh) | 2009-07-17 | 2012-05-23 | 亚伦·T.·塔波尔 | 用于具有美容功能的细胞的遗传修饰以提高美容外观的方法和组合物 |
| BR112012007090A2 (ja) | 2009-09-30 | 2018-06-05 | Shiseido Company, Ltd. | ヘパラナーゼ active inhibitor |
| EP4081235A1 (en) * | 2019-12-24 | 2022-11-02 | Juvena Therapeutics, Inc. | Heparin-associated polypeptides and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025334A (en) | 1994-04-28 | 2000-02-15 | Les Laboratoires Aeterna Inc. | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| CA2291274C (en) * | 1997-05-27 | 2006-05-16 | Sembiosys Genetics Inc. | Uses of oil bodies |
| US6372234B1 (en) | 1997-05-27 | 2002-04-16 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
| AU1597199A (en) * | 1997-11-25 | 1999-06-15 | Cornell Research Foundation Inc. | Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity |
| KR20010105403A (ko) * | 1999-03-31 | 2001-11-28 | 마빈 씨. 구트리 | 트롬보스폰딘-2 및 이의 용도 |
| US6673843B2 (en) * | 1999-06-30 | 2004-01-06 | Emory University | Curcumin and curcuminoid inhibition of angiogenesis |
-
2002
- 2002-04-10 TW TW091107218A patent/TWI233361B/zh not_active IP Right Cessation
- 2002-04-11 KR KR10-2003-7013393A patent/KR20040021598A/ko not_active Application Discontinuation
- 2002-04-11 CN CNB028112849A patent/CN100340287C/zh not_active Expired - Lifetime
- 2002-04-11 CA CA002446093A patent/CA2446093A1/en not_active Abandoned
- 2002-04-11 US US10/122,263 patent/US6712617B2/en not_active Expired - Lifetime
- 2002-04-11 KR KR1020087028640A patent/KR20080108366A/ko not_active Application Discontinuation
- 2002-04-11 JP JP2002580892A patent/JP2004526758A/ja active Pending
- 2002-04-11 WO PCT/US2002/011403 patent/WO2002083088A1/en active Application Filing
- 2002-04-11 EP EP02723824A patent/EP1377253A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004526758A5 (ja) | ||
| KR100924476B1 (ko) | 국소 글리코피롤레이트 제품 | |
| ES2310010T3 (es) | Composiciones viscosas que contienen dioxido de carbono. | |
| CA2600384C (en) | Compositions and methods for treating acne | |
| DE69826644D1 (de) | Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker | |
| JP2004505007A5 (ja) | ||
| ATE429904T1 (de) | Topisch anwendbare arzneipräparate und verfahren zur behandlung | |
| Stagnone | Superficial peeling | |
| JP2004500353A5 (ja) | ||
| RU2002121546A (ru) | Вещества, предназначенные для лечения псориаза | |
| JP2011088930A (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| JP2004508317A (ja) | 化粧品組成物および方法 | |
| EP1074245A3 (en) | Composition using mineral salts for therapeutic treatment | |
| US20160235847A1 (en) | Nail fungus treatment and composition | |
| US5753213A (en) | Pharmaceutical compositions containing 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts for reducing seborrhea | |
| JP5643872B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| JP2004532268A (ja) | 異常な角質性物質を除去するための製剤 | |
| AU709422B2 (en) | Method for topical treatment of scar tissue and related tissue reaction to trauma | |
| US20110160166A1 (en) | Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues | |
| JP5164438B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| JP2013177460A (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
| KR100809488B1 (ko) | 시이트형 하이드로겔 팩의 조성물 및 그를 이용한 시이트형 하이드로겔 팩의 제조방법 | |
| JP5993336B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| ZEGARELLI et al. | Triamcinolone Acetonide in the Treatment of Erosive Lichen Planus of the Oral Mucosae: Preliminary Report |